Compounds > n-(1-methyl-2-phenylethyl)adenosine
Page last updated: 2024-09-02

n-(1-methyl-2-phenylethyl)adenosine and theobromine

n-(1-methyl-2-phenylethyl)adenosine has been researched along with theobromine in 5 studies

Compound Research Comparison

Studies
(n-(1-methyl-2-phenylethyl)adenosine)		Trials
(n-(1-methyl-2-phenylethyl)adenosine)		Recent Studies (post-2010)
(n-(1-methyl-2-phenylethyl)adenosine)		Studies
(theobromine)		Trials
(theobromine)		Recent Studies (post-2010) (theobromine)
134041,864174274

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chopde, CT; Ghosh, AK; Mandhane, SN1
Barlinski, J; Cano, E; Frossard, N; Lagente, V1
Cho, CH; Tang, XL; Wang, HX; Wong, TM1
Naghipour, B; Roushan-zamir, F; Shafaghi, B; Zarrindast, MR1
Burnside, B; Rey, HL1

Other Studies

5 other study(ies) available for n-(1-methyl-2-phenylethyl)adenosine and theobromine

ArticleYear
Adenosine A2 receptors modulate haloperidol-induced catalepsy in rats.
    European journal of pharmacology, 1997, Jun-11, Volume: 328, Issue:2-3

    Topics: 2-Chloroadenosine; Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Catalepsy; Dopamine Antagonists; Haloperidol; Male; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Receptors, Purinergic P1; Scopolamine; Theobromine; Theophylline; Xanthines

1997
Adenosine reduces airway excitatory non-cholinergic (e-NC) contraction through both A1 and A2 adenosine receptor activation in the guinea pig.
    Fundamental & clinical pharmacology, 1997, Volume: 11, Issue:6

    Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Bronchi; Cholinergic Fibers; Dipyridamole; Dose-Response Relationship, Drug; Electric Stimulation; Guinea Pigs; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Substance P; Theobromine; Vasodilator Agents; Xanthines

1997
Reduced responsiveness of [Ca2+]i to adenosine A1- and A2-receptor stimulation in the isoproterenol-stimulated ventricular myocytes of spontaneously hypertensive rats.
    Journal of cardiovascular pharmacology, 1998, Volume: 31, Issue:4

    Topics: Adenosine; Adrenergic beta-Agonists; Animals; Calcium; Cardiotonic Agents; Electric Stimulation; Heart Ventricles; Isoproterenol; Male; Myocardium; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Theobromine; Vasodilator Agents; Xanthines

1998
Effects of adenosine receptor agents on the expression of morphine withdrawal in mice.
    European journal of pharmacology, 1999, Mar-12, Volume: 369, Issue:1

    Topics: Adenosine; Analysis of Variance; Animals; Behavior, Animal; Diarrhea; Male; Mice; Mice, Inbred Strains; Morphine; Morphine Dependence; Naloxone; Narcotic Antagonists; Narcotics; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Substance Withdrawal Syndrome; Theobromine; Xanthines

1999
Adenosine stimulates cone photoreceptor myoid elongation via an adenosine A2-like receptor.
    Journal of neurochemistry, 1999, Volume: 72, Issue:6

    Topics: Adenosine; Adenosine Triphosphate; Adenosine-5'-(N-ethylcarboxamide); Animals; Cell Size; Cells, Cultured; Darkness; Light; Neuroprotective Agents; Perciformes; Phenethylamines; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Retinal Cone Photoreceptor Cells; Theobromine

1999